Evidence map›Paper›PMID 28372522›Full record

ArticleTissue engineering. Part A2017

Mon-Tzu Li, Marissa A Ruehle, Hazel Y Stevens, Nick Servies, Nick J Willett, Sukhita Karthikeyakannan, Gordon L Warren, Robert E Guldberg, Laxminarayanan Krishnan

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Old and new biomarkers for volumetric muscle loss.Current opinion in pharmacology · 2021
    Review
  13. Article
  14. Review
  15. Current Strategies for the Regeneration of Skeletal Muscle Tissue.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mon-Tzu Li1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Marissa A Ruehle1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Hazel Y Stevens1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Nick Servies1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Nick J Willett1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Sukhita Karthikeyakannan1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Gordon L Warren4 Department of Physical Therapy, Georgia State University , Atlanta, Georgia .
Robert E Guldberg1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Laxminarayanan Krishnan1 Georgia Institute of Technology, Petit Institute for Bioengineering and Biosciences , Atlanta, Georgia .
Emory University · USGeorgia State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High velocity impact injuries can often result in loss of large skeletal muscle mass, creating defects devoid of matrix, cells, and vasculature. Functional regeneration within these regions of large volumetric muscle loss (VML) continues to be a significant clinical challenge. Large cell-seeded, space-filling tissue-engineered constructs that may augment regeneration require adequate vascularization to maintain cell viability. However, the long-term effect of improved vascularization and the effect of addition of myoblasts to vascularized constructs have not been determined in large VMLs. Here, our objective was to create a new VML model, consisting of a full-thickness, single muscle defect, in the rat biceps femoris muscle, and evaluate the ability of myoblast-seeded vascularized collagen hydrogel constructs to augment VML regeneration. Adipose-derived microvessels were cultured with or without myoblasts to form vascular networks within collagen constructs. In the animal model, the VML injury was created in the left hind limb, and treated with the harvested autograft itself, constructs with microvessel fragments (MVF) only, constructs with microvessels and myoblasts (MVF+Myoblasts), or left empty. We evaluated the formation of vascular networks in vitro by light microscopy, and the capacity of vascularized constructs to augment early revascularization and muscle regeneration in the VML using perfusion angiography and creatine kinase activity, respectively. Myoblasts (Pax7+) were able to differentiate into myotubes (sarcomeric myosin MF20+) in vitro. The MVF+Myoblast group showed longer and more branched microvascular networks than the MVF group in vitro, but showed similar overall defect site vascular volumes at 2 weeks postimplantation by microcomputed tomography angiography. However, a larger number of small-diameter vessels were observed in the vascularized construct-treated groups. Yet, both vascularized implant groups showed primarily fibrotic tissue with adipose infiltration, poor maintenance of tissue volume within the VML, and little muscle regeneration. These data suggest that while vascularization may play an important supportive role, other factors besides adequate vascularity may determine the fate of regenerating volumetric muscle defects.

Indexed as

Cells, ImmobilizedHamstring MusclesMyoblasts, SkeletalRegenerationAnimalsAutograftsCollagenDisease Models, AnimalFemaleRatsRats, Sprague-DawleyTissue ScaffoldsCollagenmuscle regenerationvascularized constructsvolumetric muscle loss

Identifiers

PMID28372522
PMCPMC5610391
OpenAlexW2604606865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.